BIOFARM
96 articole · RSS
Biofarm Sales Up 16% To RON150M In 2015
Romanian pharmaceutical producer Biofarm (BIO.RO) reported sales of RON149.7 million (EUR33.7 million) in 2015, up 16% compared with RON128.9 million a year before, the company said in a sta...
SIF Muntenia Is Biofarm’s Majority Stockholder On Ransomed Stake Cancelation
Romanian regional investment fund SIF Muntenia (SIF4.RO) owns a stake of over 50% in Romanian pharmaceutical producer Biofarm (BIO.RO), on the company’s share capital decreasing after the ca...
SIF Banat-Crisana Buys 16% Stake In Biofarm
Regional investment fund SIF Banat-Crisana (SIF1.RO) bought a 16.8% stake in Romanian pharmaceutical producer Biofarm (BIO.RO) for 51,000 lei, on the Bucharest Stock Exchange’s August 24 ses...
Biofarm Net Profit Up 2% to RON15M In First Half
Romanian pharmaceutical producer Biofarm (BIO.RO) Thursday reported a first-half net profit of 15 million lei (EUR3.4 million), slightly up from RON14.7 million in the year-earlier period.
Biofarm Reports 37% Higher Net Profit in 1Q
Romanian medicine producer Biofarm (BIO.RO) reported a net profit of 13.6 million lei (EUR3 million) for the first quarter, up 37.3% from the year earlier period, on higher sales.
Biofarm Goes Shopping, Wants To Earmark RON14M For Acquisitions
Romanian drug maker Biofarm Bucuresti (BIO.RO) wants to acquire a pharmaceutical company to gain market share and grow its own business.
Biofarm Sales Rose 9.5% Last Year, To RON128.9M
Sales of pharmaceutical manufacturer Biofarm (BIO.RO) rose 9.5% last year, to RON128.9 million (around EUR29.1 million), while the company's net profit grew 2%, to RON26.1 million (EUR5.9 mi...
Biofarm 9-Month Sales Up 4.6% On Year, To RON88.5M
Romanian drugmaker Biofarm (BIO.RO) Friday said its sales rose 4.6% to 89.48 million lei (EUR20.2 million) in the first nine months of 2014, from RON85.57 million in the same period in 2013.
Biofarm Buyback Offer Largely Oversubscribed
The buyback offer launched by pharmaceutical producer Biofarm (BIO.RO) on the Bucharest stock exchange was heavily oversubscribed, as the company’s main shareholders placed orders to sell th...